Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections

Journal of Infection and Chemotherapy

Volumn 17, Issue 5, 2011, Pages 646-651

  Shigemura, Katsumi ^a,b,c   Tanaka, Kazushi ^b   Adachi, Masayo ^a   Yamashita, Masuo ^a   Arakawa, Soichi ^b   Fujisawa, Masato ^b  

^a Akashi Municipal Hospital   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c Shinko Hospital   (Japan)

Author keywords

Antibiotic use; Chronological change; Drug resistance; Escherichia coli; Urinary tract infection

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFCAPENE; CEFOTIAM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MINOCYCLINE; PIPERACILLIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTITIS; DRUG MONITORING; DRUG USE; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PYELONEPHRITIS; RETROSPECTIVE STUDY; TREND STUDY; URINARY TRACT INFECTION;

EID: 84855453039     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-011-0241-2     Document Type: Article

References (15)

1. Catal F, Bavbek N, Bayrak O, Karabel M, Karabel D, Odemis E, et al. Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006. Int Urol Nephrol. 2009;41:953-7.
2. De Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N. Urinary tract infections in Brescia, Italy: Etiology of uropathogens and antimicrobial resistance of common uropathogens. Med Sci Monit 2007;13:BR136-BR144. (Pubitemid 46855567)
3. Gales AC, Sader HS, Jones RN,SENTRYParticipants Group (Latin America). Urinary tract infection trends in Latin American hospitals: Report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis. 2002;44:289-99. (Pubitemid 35454104)
4. Muratani T, Matsumoto T. Bacterial resistance to antimicrobials in urinary isolates. Int J Antimicrob Agents. 2004;24:S28-31. (Pubitemid 39208856)
5. Kader AA, Angamuthu K. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. Saudi Med J. 2005;26:956-9. (Pubitemid 41015082)
6. Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from communityacquired urinary tract infections in Turkey. J Antimicrob Chemother. 2005;56:914-8. (Pubitemid 41631917)
7. Hillier S, Roberts Z, Dunstan F, Butler C, Howard A, Palmer S. Prior antibiotics and risk of antibiotic-resistant communityacquired urinary tract infection: A case-control study. J Antimicrob Chemother. 2007;60:92-9. (Pubitemid 47073281)
8. Matsumoto T. Urinary tract infection. In: Kobayashi H, Kumazawa J, editors. Guideline for antibiotics treatments. 2nd ed. Tokyo: Japanese Association of Infectious Diseases and Japanese Society of Chemotherapy 2003 p. 76-82.
9. Muratani T, Matsumoto T. Urinary tract infection caused by fluoroquinolone-and cephem-resistant Enterobacteriaceae. Int J Antimicrob Agents. 2006;28:S10-3.
10. Colodner R, Kometiani I, Chazan B, Raz R. Risk factors for community-acquired urinary tract infection due to quinoloneresistant E. coli. Infection. 2008;36:41-5.
11. Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med. 2008;121:876-84.
12. Oshiro T, Fukutomi Y, Takayanagi M, Kusaba K, Nagasawa Z, Aoki Y, et al. Antibacterial activity of oral cephems against various clinically isolated strains. Jpn J Antibiot. 2003;56: 681-90. (Pubitemid 38139900)
13. Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M, Kanda M, et al. In vitro susceptibilities to levofloxacin and various antibacterial agents of 18,639 clinical isolates obtained from 77 centers in 2004. Jpn J Antibiot. 2006;59:428-51. (Pubitemid 46212601)
14. Azap OK, Arslan H, Serefhanoǧlu K, Colakoǧlu S, Erdoǧan H, Timurkaynak F, et al. Risk factors for extended-spectrum betalactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010;16:147-51.
15. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum betalactamases. J Antimicrob Chemother. 2006;57:780-3.